Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients

BACKGROUND: Coronavirus disease 2019 (COVID-19) causing severe acute respiratory distress syndrome caused by coronavirus 2 (SARS-CoV-2) still has no solid effective therapy. From previous studies, dexamethasone has led to a decrease in mortality in patients who required oxygen supplementation mainly...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeed, Mohammed Abdel Monem, Mohamed, Alaa Hussein, Owaynat, Ahmed Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853130/
https://www.ncbi.nlm.nih.gov/pubmed/35194371
http://dx.doi.org/10.1186/s43162-022-00113-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853130/
https://www.ncbi.nlm.nih.gov/pubmed/35194371
http://dx.doi.org/10.1186/s43162-022-00113-z

Ejemplares similares